12-Month effects of once-weekly sustained-release growth hormone treatment in adults with GH deficiency.
Pituitary., Aug (2012)
Clinical characteristics, timing of peak responses and safety aspects of two dosing regimens of the glucagon stimulation test in evaluating growth hormone and cortisol secretion in adults.
Pituitary., Jul (2012)
A longer interval without GH replacement and female gender are associated with lower bone mineral density in adults with childhood-onset GH deficiency: a KIMS database analysis.
Eur. J. Endocrinol., Sep;167(3):343-51 (2012)
A review of guidelines for use of growth hormone in pediatric and transition patients.
Pituitary., Sep;15(3):301-10 (2012)
A retail market study of organic and conventional potatoes (Solanum tuberosum): mineral content and nutritional implications.
Int J Food Sci Nutr., Jun;63(4):393-401 (2012)
How useful are serum IGF-I measurements for managing GH replacement therapy in adults and children?
Pituitary., Jun;15(2):126-34 (2012)
American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly--2011 update.
Endocr Pract., 17 Suppl 4:1-44 (2011 Jul-Aug)
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly--2011 update: executive summary.
Endocr Pract., 17(4):636-46 (2011 Jul-Aug)
Effects of once-weekly sustained-release growth hormone: a double-blind, placebo-controlled study in adult growth hormone deficiency.
J. Clin. Endocrinol. Metab., Jun;96(6):1718-26 (2011)
Unreplaced sex steroid deficiency, corticotropin deficiency, and lower IGF-I are associated with lower bone mineral density in adults with growth hormone deficiency: a KIMS database analysis.
J. Clin. Endocrinol. Metab., May;96(5):1516-23 (2011)
Acromegaly: a review of current medical therapy and new drugs on the horizon.
Neurosurg Focus., Oct;29(4):E15 (2010)
End of life and the advance directive.
Tenn Med., Feb;103(2):19-26 (2010)
American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients - 2009 update.
Endocr Pract., 15 Suppl 2:1-29 (2009 Sep-Oct)
Effectiveness of self- or partner-administration of an extended-release aqueous-gel formulation of lanreotide in lanreotide-naÃ¯ve patients with acromegaly.
Pituitary., Jun;13(2):115-22 (2010)
American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients - 2009 update: executive summary of recommendations.
Endocr Pract., 15(6):580-6 (2009 Sep-Oct)
Clinical review: Is lack of recombinant growth hormone (GH)-releasing hormone in the United States a setback or time to consider glucagon testing for adult GH deficiency?
J. Clin. Endocrinol. Metab., Aug;94(8):2702-7 (2009)
A retrospective analysis of prevalence of gastrointestinal parasites among school children in the Palajunoj Valley of Guatemala.
J Health Popul Nutr., Feb;27(1):31-40 (2009)
Prevalence of GH and other anterior pituitary hormone deficiencies in adults with nonsecreting pituitary microadenomas and normal serum IGF-1 levels.
Clin. Endocrinol. (Oxf)., Aug;69(2):292-8 (2008)
Evaluation of the pituitary function with insulin tolerance (hypoglycaemia) testing: are there any differences using insulin lispro compared to regular insulin?
Horm. Res., 69(4):233-9 (2008)
Is further evaluation for growth hormone (GH) deficiency necessary in fibromyalgia patients with low serum insulin-like growth factor (IGF)-I levels?
Growth Horm. IGF Res., Feb;17(1):82-8 (2007)